» Articles » PMID: 37240548

Risk Factors for Poor Outcome After Palliative Surgery for Metastatic Spinal Tumors

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 May 27
PMID 37240548
Authors
Affiliations
Soon will be listed here.
Abstract

Palliative surgery is performed to improve the quality of life of patients with spinal metastases. However, it is sometimes difficult to achieve the expected results because the patient's condition, and risk factors related to poor outcomes have not been well elucidated. This study aimed to evaluate the functional outcomes and investigate the risk factors for poor outcomes after palliative surgery for spinal metastasis. We retrospectively reviewed the records of 117 consecutive patients who underwent palliative surgery for spinal metastases. Neurological and ambulatory statuses were evaluated pre- and post-operatively. Poor outcomes were defined as no improvement or deterioration in functional status or early mortality, and the related risk factors were analyzed using multivariate logistic regression analysis. The results showed neurological improvement in 48% and ambulatory improvement in 70% of the patients with preoperative impairment, whereas 18% of the patients showed poor outcomes. In the multivariate analysis, low hemoglobin levels and low revised Tokuhashi scores were identified as risk factors for poor outcomes. The present results suggest that anemia and low revised Tokuhashi scores are related not only to life expectancy but also to functional recovery after surgery. Treatment options should be carefully selected for the patients with these factors.

Citing Articles

Comprehensive Insights into Metastasis-Associated Spinal Cord Compression: Pathophysiology, Diagnosis, Treatment, and Prognosis: A State-of-the-Art Systematic Review.

Vavourakis M, Sakellariou E, Galanis A, Karampinas P, Zachariou D, Tsalimas G J Clin Med. 2024; 13(12).

PMID: 38930119 PMC: 11205147. DOI: 10.3390/jcm13123590.

References
1.
Yamashita T, Aota Y, Kushida K, Murayama H, Hiruma T, Takeyama M . Changes in physical function after palliative surgery for metastatic spinal tumor: association of the revised Tokuhashi score with neurologic recovery. Spine (Phila Pa 1976). 2008; 33(21):2341-6. DOI: 10.1097/BRS.0b013e3181878733. View

2.
Fumet J, Truntzer C, Yarchoan M, Ghiringhelli F . Tumour mutational burden as a biomarker for immunotherapy: Current data and emerging concepts. Eur J Cancer. 2020; 131:40-50. PMC: 9473693. DOI: 10.1016/j.ejca.2020.02.038. View

3.
Fisher C, DiPaola C, Ryken T, Bilsky M, Shaffrey C, Berven S . A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976). 2010; 35(22):E1221-9. DOI: 10.1097/BRS.0b013e3181e16ae2. View

4.
Cella D, Lai J, Chang C, Peterman A, Slavin M . Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002; 94(2):528-38. DOI: 10.1002/cncr.10245. View

5.
Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View